FR-3129155-B1 - MITOCHONDRIAL GENOTYPIC SCORES: PROGNOSTIC MARKERS IN CHEMO-SENSITIVE CANCER
FR3129155B1FR 3129155 B1FR3129155 B1FR 3129155B1FR-3129155-B1
Abstract
The present invention relates to a prognostic risk score for chemosensitive cancer, in particular acute myeloid leukemia (AML), based on somatic genetic abnormalities affecting certain genes of the mitochondrial genome. Abbreviated figure: Fig. 2A
Inventors
- MONDET JULIE
- MOSSUZ PASCAL
Assignees
- UNIV GRENOBLE ALPES
- CENTRE HOSPITALIER UNIV GRENOBLE ALPES HOPITAL NORD
- CENTRE NAT RECH SCIENT
- INST NAT SANTE RECH MED
Dates
- Publication Date
- 20260501
- Application Date
- 20211116
- Priority Date
- 20211116